A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes
Wieneke A. Buikhuisen(The Netherlands Cancer Institute)
Cited by 42